...BRCA2. Conversely, the majority of families with male and female breast cancer were due to BRCA2 (76%). The largest prop...
...BRCA2 and p53 mutations in tumors. p53 mutations are more frequent in BRCA2 mutation carriers than they are in controls....
...BRCA2 mutation may be augmenting the risk of male breast cancer conferred by the BRCA2 mutation.
In view of the recent reports of recurrent mutations in BRCA1 and BRCA2 in the Ashkenazi Jewish population, we have unde...
...BRCA2 mutations may be less than previously estimated. Antiestrogens with lesser risks than tamoxifen hold promise for c...
...BRCA2 gene were now analyzed for mutations in the BRCA1 gene. The coding region and splice boundaries of BRCA1 were anal...
...BRCA2 gene, while patients with familial pancreatitis due to a mutated cationic trypsinogen gene have a greatly increase...
...BRCA2 genes, for example, also lead to pancreatic cancer, but the gene responsible for familial pancreatic cancer has no...
...BRCA2 status (P = 0.34, P = 0.29 respectively). LOH at BRCA2 does not therefore appear to be a major prognostic marker i...
...BRCA2 mutations; two frameshifts and one putative missense mutation were identified. One of the frameshifts was detected...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
